Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
Borgquist S, Djerbi S, Pontén F, Anagnostaki L, Goldman M, Gaber A, Manjer J, Landberg G, Jirström K. Borgquist S, et al. Int J Cancer. 2008 Sep 1;123(5):1146-53. doi: 10.1002/ijc.23597. Int J Cancer. 2008. PMID: 18528862
Furthermore, the potential influence of estrogen exposure on HMG-CoAR expression was assessed by performing Cox's proportional hazards analyses of the relationship between the use of hormone replacement therapy (HRT), obesity (waist circumference) and tumour-cell specific …
Furthermore, the potential influence of estrogen exposure on HMG-CoAR expression was assessed by performing Cox's proportional hazard …
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
Berglund P, Stighall M, Jirström K, Borgquist S, Sjölander A, Hedenfalk I, Landberg G. Berglund P, et al. Cancer Res. 2005 Nov 1;65(21):9727-34. doi: 10.1158/0008-5472.CAN-04-3984. Cancer Res. 2005. PMID: 16266993
Cell cycle deregulation is a prerequisite in tumor development and overexpression of cyclin E, a major G1-S regulator, is often observed in breast cancer and is further linked to poor prognosis. ...
Cell cycle deregulation is a prerequisite in tumor development and overexpression of cyclin E, a major G1-S regulator, is often obser …
Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators.
Borgquist S, Wirfält E, Jirström K, Anagnostaki L, Gullberg B, Berglund G, Manjer J, Landberg G. Borgquist S, et al. Breast Cancer Res. 2007;9(1):R11. doi: 10.1186/bcr1644. Breast Cancer Res. 2007. PMID: 17254341 Free PMC article.
Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
Borgquist S, Anagnostaki L, Jirström K, Landberg G, Manjer J. Borgquist S, et al. Int J Cancer. 2007 May 15;120(10):2202-7. doi: 10.1002/ijc.22542. Int J Cancer. 2007. PMID: 17278089
The difference corresponded to an adjusted relative risk (95% confidence interval) of 3.01 (2.35-3.84) as obtained using a Cox's proportional hazards analysis. ...
The difference corresponded to an adjusted relative risk (95% confidence interval) of 3.01 (2.35-3.84) as obtained using a Cox's prop …
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
Borgquist S, Holm C, Stendahl M, Anagnostaki L, Landberg G, Jirström K. Borgquist S, et al. J Clin Pathol. 2008 Feb;61(2):197-203. doi: 10.1136/jcp.2006.040378. J Clin Pathol. 2008. PMID: 18223096
Parity in relation to survival following breast cancer.
Butt S, Borgquist S, Garne JP, Landberg G, Tengrup I, Olsson A, Manjer J. Butt S, et al. Eur J Surg Oncol. 2009 Jul;35(7):702-8. doi: 10.1016/j.ejso.2008.03.017. Epub 2008 May 19. Eur J Surg Oncol. 2009. PMID: 18490128
Corresponding relative risks, with 95% confidence intervals (CI), were obtained using Cox's proportional hazards analysis. All analyses were adjusted for potential prognostic factors and stratified for age, menopausal status and diagnostic period. ...
Corresponding relative risks, with 95% confidence intervals (CI), were obtained using Cox's proportional hazards analysis. All analys …
Plant foods and oestrogen receptor alpha- and beta-defined breast cancer: observations from the Malmo Diet and Cancer cohort.
Sonestedt E, Borgquist S, Ericson U, Gullberg B, Landberg G, Olsson H, Wirfält E. Sonestedt E, et al. Carcinogenesis. 2008 Nov;29(11):2203-9. doi: 10.1093/carcin/bgn196. Epub 2008 Aug 18. Carcinogenesis. 2008. PMID: 18711147
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
Borgquist S, Jögi A, Pontén F, Rydén L, Brennan DJ, Jirström K. Borgquist S, et al. Breast Cancer Res. 2008;10(5):R79. doi: 10.1186/bcr2146. Epub 2008 Sep 22. Breast Cancer Res. 2008. PMID: 18808688 Free PMC article.
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H, Landberg G, Wirfält E. Sonestedt E, et al. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3241-51. doi: 10.1158/1055-9965.EPI-08-0393. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18990767
121 results
Jump to page
Feedback